BCRL Prevention Pilot
NCT01166672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2012-10-12
Summary
The purpose of this study is to establish feasiblity of recruiting obese breast cancer survivors at the end of treatment, getting those survivors to lose weight and attend follow-up visits for 6 months.
Conditions
Sponsors & Collaborators
-
Abramson Cancer Center at Penn Medicine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- United States
Study Locations
More Related Trials
-
Study on Breast Cancer Patient Perspectives of Exercise
NCT02559362 ·Status: COMPLETED
-
Breast Cancer Prevention Education
NCT01299623 ·Status: COMPLETED ·Phase: NA
-
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
NCT03161600 ·Status: COMPLETED ·Phase: NA
-
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
NCT00291096 ·Status: RECRUITING
-
Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue
NCT03657628 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
NCT07214610 ·Status: RECRUITING ·Phase: NA
-
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Body Mass Index on Outcomes of Breast Cancer Management
NCT03429504 ·Status: UNKNOWN
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer
NCT02530008 ·Status: ACTIVE_NOT_RECRUITING
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
RPFNA Assessment of Exercise Effect in Breast Cancer
NCT01961128 ·Status: COMPLETED ·Phase: NA
-
Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer
NCT05250336 ·Status: UNKNOWN
-
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
NCT07066189 ·Status: RECRUITING ·Phase: NA
-
Partial Breast Irradiation in a Low-risk Population Screened With MRI
NCT01255553 ·Status: WITHDRAWN ·Phase: NA
-
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
NCT04371913 ·Status: RECRUITING ·Phase: NA
-
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
NCT05772390 ·Status: RECRUITING ·Phase: PHASE2
-
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology
NCT05441098 ·Status: UNKNOWN
-
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661 ·Status: COMPLETED
-
Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care
NCT05400941 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Intensity Modulated Radiotherapy for Breast Cancer
NCT00594477 ·Status: COMPLETED ·Phase: PHASE1
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Planning Grant for TOPS for Breast Cancer Survivors
NCT06658912 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid
NCT05140252 ·Status: COMPLETED ·Phase: NA